Skip to main content
SpringerLink
Log in

Functional Classification and Response to Psychotropic Drugs

  • Conference paper
Methodology of the Evaluation of Psychotropic Drugs

Part of the book series: Psychopharmacology Series ((PSYCHOPHARM,volume 8))

Abstract

Psychopathologically defined diagnoses represent guidelines for the application of drugs and serve as selection criteria for the evaluation of potentially useful psychopharmacological agents. Therefore, the success of research in drug evaluation strongly depends on the conceptual frameworks of diagnostic classification and how these change. For instance, at the beginning of the era of antidepressants 30 years ago, the efficacy of antidepressants was thought to be restricted to patients with endogenous depression, but since then their therapeutic spectrum has broadened: first to the “depressive syndrome” and then, due to the growing acceptance of DSM-III, to the major depressive episode. Now, even further indications for antidepressants, especially for panic disorder and generalized anxiety disorder, have been suggested.

Dedicated to Professor Dr. Hanns Hippius on the occasion of his 65th birthday.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aldenhoff JB, Schlegel S, Benkert O (1989) Gallopamil influences the manic syndrome by reducing excitement, (submitted)

    Google Scholar 

  • Angst H, Scharfetter C, Stassen HH (1983) Classification of schizo-affective patients by multidimensional scaling and cluster analyses. Psychopathology 16: 254–264

    Article  CAS  Google Scholar 

  • Angst J, Dobler-Mikola A (1985) The Zurich Study. VI. A continuum from depression to anxiety disorders. Eur Arch Psychiatry Neurol Sci 235: 179–186

    Article  PubMed  CAS  Google Scholar 

  • Benkert O, Holsboer F (1984) Effect of sulpiride in endogenous depression. In: Sedvall G (ed) The use of substituted benzamides in psychiatry. Acta Psychiatr Scand [Suppl 311] 39: 43–48

    Google Scholar 

  • Buchsbaum MS, Haier RJ (1983) Psychopathology: biological approaches. Annu Rev Psychol 34: 401–430

    Article  PubMed  CAS  Google Scholar 

  • Cassano GB, Musetti L, Perugi G, Soriani A, Mignani V, McNair DM, Akiskal HS (1988) A proposed new approach to the clinical subclassification of depressive illness. Pharmacopsychiatry 21: 19–23

    Article  PubMed  CAS  Google Scholar 

  • Crow TJ (1986) The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry 149: 419–429

    Article  PubMed  CAS  Google Scholar 

  • Cowdry RW, Gardner DL (1988) Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 45: 111–119

    PubMed  CAS  Google Scholar 

  • DiMascio A, Weissmann MM, Prusoff BA, Neu C, Zwilling M, Klerman GL (1979) Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 36: 1450–1456

    PubMed  CAS  Google Scholar 

  • Evans RW, Gualtieri CT (1985) Carbamazepine: a neuropsychological and psychiatric profile. Raven Press ( Clin Neuropharmacol ), New York, pp 221–241

    Google Scholar 

  • Frost RE, Messika FS (1983) Clinical uses of lithium salts. Brain Res Bull 11: 219–231

    Article  PubMed  CAS  Google Scholar 

  • Giller Jr E, Bialos D, Riddle MA, Waldo MC (1988) MAOI treatment response: multiaxial assessment. J Affective Disord 14: 171–175

    Article  Google Scholar 

  • Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO (1986) Borderline and schizotypal personality disorders treated with low-dose thiothixene versus placebo. Arch Gen Psychiatry 43: 680–686

    PubMed  CAS  Google Scholar 

  • Goodwin GM, Johnson DAW, McCreadie RG (1989) Comment on the North wick Park ‘functional’ psychosis study. Br J Psychiatry 154: 406–409

    Article  PubMed  CAS  Google Scholar 

  • Griesinger W (1867) Die Pathologie und Therapie der psychischen Krankheiten. Wreden, Braunschweig

    Google Scholar 

  • Helmchen H (1988) Methodological and strategical considerations in schizophrenia research. Compr Psychiatry 29: 337–354

    Article  PubMed  CAS  Google Scholar 

  • Hollister LE (1987) Strategies for research in clinical psychopharmacology. In: Meitzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 31–38

    Google Scholar 

  • Johnstone EC, Crow TJ, Frith CD, Owens DGC (1988) The Northwick Park “functional” psychosis study: diagnosis and treatment response. Lancet 1: 119–125

    Article  Google Scholar 

  • Kahn RJ, McNair DM, Lipman RS (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders: II. Efficacy in anxious out-patients. Arch Gen Psychiatry 43: 79–85

    PubMed  CAS  Google Scholar 

  • Klein DF (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacology 5: 397–408

    Article  CAS  Google Scholar 

  • Klerman GL (1983) The significance of DSM-III in American psychiatry. In: Spitzer RL, Williams JB, Skodol AE (eds) International perspectives on DSM-III. American Psychiatric Press, Washington, DC

    Google Scholar 

  • Kocsis JH, Frances AJ (1987) A critical discussion of DSM-III dysthymic disorder. Am J Psychiatry 144: 1534–1542

    PubMed  CAS  Google Scholar 

  • Koppi S, Eberhardt G, Haller R, König P (1987) Calcium-channel-blocking agent in the treatment of acute alcohol withdrawal — caroverine versus meprobamate in a randomized double-blind study. Neuropsychobiology 17: 49–52

    Article  PubMed  CAS  Google Scholar 

  • Liebowitz MR, Klein DF, Quitkin FM, Stewart JW, McGrath PJ (1984) Clinical implications of diagnostic subtypes of depression. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders, vol 1. William and Wildings, Baltimore London, pp 107–120

    Google Scholar 

  • Lipman RS, Covi L, Rickeis K, McNair DM, Downing R (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders: I. Efficacy in depressed out-patients. Arch Gen Psychiatry 43: 68–77

    PubMed  CAS  Google Scholar 

  • Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O (1990) Subtyping panic disorder by avoidance behaviour and major depression: comorbidity and prediction of response to treatment, (submitted)

    Google Scholar 

  • Maj M (1985) Clinical course and outcome of schizoaffective disorders — a three-year follow-up study. Acta Psychiatr Scand 72: 542–550

    Article  PubMed  CAS  Google Scholar 

  • McNair DM, Kahn RJ (1981) Imipramine compared with a benzodiazepine for agoraphobia. In: Klein DF, Rabkin J (eds) Anxiety: new research and changing concepts. Raven Press, New York, pp 69–79

    Google Scholar 

  • Paykel ES, Freeling P, Hollyman JA (1988) Are tricyclic antidepressants useful for mild depression? A placebo controlled trial. Pharmacopsychiatry 21: 15–18

    Article  PubMed  CAS  Google Scholar 

  • Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R (1987) Fluvoxamine treatment of obsessive compulsive disorder. Am J Psychiatry 144: 1543–1548

    PubMed  CAS  Google Scholar 

  • Philipp M, Maier W (1986) The polydiagnostic interview: a structured interview for polydiagnostic classification of psychiatric patients. Psychopathology 19: 175–185

    Article  PubMed  CAS  Google Scholar 

  • Pöldinger W, Sieberns S (1983) Depression-inducing and antidepressive effects of neuroleptics. Experiences with flupenthixol and flupenthixol decanoate. Neuropsychobiology 10: 131–136

    Article  PubMed  Google Scholar 

  • Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd D (1985) Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 5: 320–327

    PubMed  Google Scholar 

  • Praag von HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML (1987) Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affective Disord 13: 1–8

    Article  Google Scholar 

  • Robertson MM, Trimble MR (1982) Major tranquillisers used as antidepressants. J Affective Disord 4: 173–193

    Article  CAS  Google Scholar 

  • Scott J, Barker WA, Eccleston D (1988) The Newcastle chronic depression study. Br J Psychiatry 152: 28–33

    Article  PubMed  CAS  Google Scholar 

  • Shader RI, Goodman M, Gever J (1982) Panic disorder: current perspectives. J Clin Psychopharmacol 2: 2S–10s

    Article  PubMed  CAS  Google Scholar 

  • Sheehan DV (1982) Panic attacks and phobias. N Engl J Med 307: 156–158

    Article  PubMed  CAS  Google Scholar 

  • Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM (1986) Progress in pharmacotherapy of borderline disorders: a double-blind study of haloperidol, amitriptyline, and placebo. Arch Gen Psychiatry 43: 691–697

    PubMed  CAS  Google Scholar 

  • Spiker DG, Weiss JC, Dealy RS et al. (1985) The pharmacological treatment of delusional depression. Am J Psychiatry 142: 430–436

    PubMed  CAS  Google Scholar 

  • Strauss JS, Carpenter WT (1974) The prediction of outcome in schizophrenia. Arch Gen Psychiatry 31: 37–42

    PubMed  CAS  Google Scholar 

  • Swift WJ, Andrews D, Barklage NE (1986) The relationship between affective disorder and eating disorders: a review of the literature. Am J Psychiatry 143 (3): 290–299

    PubMed  CAS  Google Scholar 

  • Taylor CB, Sheikh J, Agras WS, Roth WT, Margraf J, Ehlers A, Maddock RJ, Gossard D (1986) Ambulatory heart rate changes in patients with panic attacks. Am J Psychiatry 143: 478–482

    PubMed  CAS  Google Scholar 

  • Thoren P, Asberg M, Cronholm B, Hornestedt L, Traskman L (1980) Clomipramine treatment of obsessive-compulsive disorder: I. A controlled clinical trial. Arch Gen Psychiatry 37: 1281–1285

    PubMed  CAS  Google Scholar 

  • Turner SM, Jacob RG, Beidel D, Himmelhoch J (1985) Fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 5: 207–212

    Article  PubMed  CAS  Google Scholar 

  • Tyrer P, Murphy S, Kindgdon D, Brothwell J, Gregory S, Seivewright N, Ferguson B, Barczak P, Darling C, Johnson AL (1988) The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet: 235–240

    Google Scholar 

  • Weissman MM, Leaf PJ, Livingston Bruce M, Florio L (1988) The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry 145: 815–819

    PubMed  CAS  Google Scholar 

  • Wetzel H, Heuser I, Benkert O (1987) Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 175: 240–242

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Klinik der Universität Mainz, Untere Zahlbacher Straße 8, 6500, Mainz, Germany

    O. Benkert

Authors
  1. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Klinikum der Johannes Gutenberg-Universität Mainz, Untere Zahlbacher Straße 8, 6500, Mainz, Germany

    Wolfgang Maier

  2. Department of Psychiatry, University of Pennsylvania, 203 Piersol Building, University Hospital, 3400 Spruce Street, 19104-4283, Philadelphia, PA, USA

    Karl Rickels M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Benkert, O. (1990). Functional Classification and Response to Psychotropic Drugs. In: Benkert, O., Maier, W., Rickels, K. (eds) Methodology of the Evaluation of Psychotropic Drugs. Psychopharmacology Series, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75370-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75370-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-75372-5

  • Online ISBN: 978-3-642-75370-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation